Please login to the form below

Not currently logged in
Email:
Password:

antitrust investigation

This page shows the latest antitrust investigation news and features for those working in and with pharma, biotech and healthcare.

France wants Avastin used in place of Lucentis

France wants Avastin used in place of Lucentis

taking the lead from an earlier antitrust investigation in the country that resulted in the levying of a 182.5m fine.

Latest news

  • Lundbeck still 'appalled' by EC's €94m anti-competition fine Lundbeck still 'appalled' by EC's €94m anti-competition fine

    An EC investigation concluded in June the Danish pharma company had collaborated with several other companies to delay the entry of generic competition for its big-selling antidepressant Celexa/ Cipramil (citalopram).

  • Novartis, Roche under scrutiny in Italy on Avastin/Lucentis collusion claims Novartis, Roche under scrutiny in Italy on Avastin/Lucentis collusion claims

    Antitrust authorities in Italy open investigation into the pharma companies. Antitrust authorities in Italy have opened an investigation into claims Novartis and Roche colluded to restrict the availability of a

  • EC to investigate Novartis and J&J in antitrust probe EC to investigate Novartis and J&J in antitrust probe

    Claims companies agreed to delay entry of generic painkiller. Johnson &Johnson and Novartis are the latest pharma companies to face a European Commission investigation into anticompetitive practices, this time for allegedly ... The 'statement of

  • EC investigates J&J/Novartis over fentanyl

    The European Commission has launched an antitrust investigation to assess if Johnson &Johnson and Novartis' generics division, Sandoz, hindered entry of generic versions of pain drug fentanyl into the Netherlands. ... The European Commission (EC) has

  • EU drops Boehringer Ingelheim patent probe

    The European Union has dropped an antitrust investigation into Boehringer Ingelheim's patents for chronic obstructive pulmonary disease (COPD) treatments. ... The commission will remain vigilant that companies' behaviour respect antitrust law and do not

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics